Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions such as MS.

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

A study of 125 children with POMS and 145 without major health disorders found that epigenetic age tended to be higher in children with POMS.